Literature DB >> 18829712

Improvements in glycaemic control and cardiovascular risk factors in a cohort of patients with type 1 diabetes over a 5-year period.

S A Saunders1, M Wallymhamed, I A Macfarlane.   

Abstract

BACKGROUND: Management of patients with type 1 diabetes in the UK has changed over the past 20 years. The targets for glycaemic control, blood pressure and cholesterol are lower. We examined a cohort of patients with type 1 diabetes who have been through these changes to assess their effects. DESIGN AND METHODS: A cohort of patients with type 1 diabetes who attended a secondary care outpatient diabetes clinic between 1991 and 1996 were reviewed in 2001 and 2006. Comparison is made between current biophysical markers and those obtained in 2001.
RESULTS: Only 81.9% (n = 214) of the original cohort attended in 2006. These patients had an average duration of diabetes of 23.46 (SD +/- 8.06) years. There were 134 male patients (62.62%). In these patients HbA1c had reduced by 0.4% (absolute reduction); a relative reduction of 4.41% (P = 0.0001). Statistically significant reductions in diastolic blood pressure (74-68 mmHg) and total cholesterol (5.37-4.62 mmol/l) occurred. However, weight (75.04-82.31 kg) and BMI (25.32-27.72 kg/m(2)) significantly increased. There was no statistically significant change in insulin dose (units/kg), serum creatinine, urinary ACR or systolic blood pressure.
CONCLUSION: An urban setting, mobile population and patient non-attendance can complicate modern diabetes care. Despite these difficulties, input by the diabetes team working with the patients can achieve small improvements in Hba1c and cardiovascular risk factors by increased use of long acting insulins, metformin, statins and blood pressure medication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829712     DOI: 10.1093/qjmed/hcn125

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  How does the impact of a community trial on cardio-metabolic risk factors differ in terms of gender and living area? Findings from the Isfahan healthy heart program.

Authors:  Nizal Sarrafzadegan; Roya Kelishadi; Mansour Siavash; Gholamhossein Sadri; Hossein Malekafzali; Masoud Pourmoghaddas; Shahin Shirani; Maryam Boshtam; Sedigheh Asgary; Noushin Mohammadifard; Ahmad Bahonar; Babak Eshrati; Farhad Ghamsari
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

2.  Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.

Authors:  Shona J Livingstone; Helen C Looker; Eleanor J Hothersall; Sarah H Wild; Robert S Lindsay; John Chalmers; Stephen Cleland; Graham P Leese; John McKnight; Andrew D Morris; Donald W M Pearson; Norman R Peden; John R Petrie; Sam Philip; Naveed Sattar; Frank Sullivan; Helen M Colhoun
Journal:  PLoS Med       Date:  2012-10-02       Impact factor: 11.069

3.  The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.

Authors:  Phil McEwan; Hayley Bennett; Jonathan Fellows; Jennifer Priaulx; Klas Bergenheim
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

4.  Adequate prescribing of medication does not necessarily translate into good control of diabetes mellitus.

Authors:  Antanas Norkus; Rytas Ostrauskas; Rimantas Zalinkevičius; Lina Radzevičienė; Rita Sulcaite
Journal:  Patient Prefer Adherence       Date:  2013-07-08       Impact factor: 2.711

5.  Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c , weight and hypoglycaemic event incidence.

Authors:  P McEwan; H Bennett; K Bolin; M Evans; K Bergenheim
Journal:  Diabet Med       Date:  2018-02-28       Impact factor: 4.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.